Outside Consultant Will Evaluate FDA's Postmarketing Studies Practices

Your AI-Trained Oncology Knowledge Connection!

Outside Consultant Will Evaluate FDA's Postmarketing Studies Practices

June 1, 2006

Publication

Article

Oncology NEWS InternationalOncology NEWS International Vol 15 No 6

Volume 15

Issue 6

The FDA has awarded a $1.09 million contract for an evaluation of the agency's process of establishing postmarketing, or phase IV, studies. The consulting firm of Booz Allen Hamilton will conduct the 1-year evaluation and make recommendations to the agency for improving and standardizing the process.

ROCKVILLE, MarylandThe FDA has awarded a $1.09 million contract for an evaluation of the agency's process of establishing postmarketing, or phase IV, studies. The consulting firm of Booz Allen Hamilton will conduct the 1-year evaluation and make recommendations to the agency for improving and standardizing the process.

Articles in this issue

Triple-Negative Cancers More Common in Young Black Pts

Artists Turn Flowers & Curves Into 'Forms' and 'Figures'

Study to Examine Outcomes Disparities in Pediatric ALL

Thalidomide Has 'Changed the Paradigm' in Myeloma Rx

CA4P Gets Orphan Drug Status

Testicular Ca Survivors at Increased Risk for CV Events

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!

Outside Consultant Will Evaluate FDA's Postmarketing Studies Practices

Newsletter